282 related articles for article (PubMed ID: 31311394)
1. Phosphodiesterase 5 Associates With β2 Adrenergic Receptor to Modulate Cardiac Function in Type 2 Diabetic Hearts.
West TM; Wang Q; Deng B; Zhang Y; Barbagallo F; Reddy GR; Chen D; Phan KS; Xu B; Isidori A; Xiang YK
J Am Heart Assoc; 2019 Aug; 8(15):e012273. PubMed ID: 31311394
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of type 5 phosphodiesterase counteracts β2-adrenergic signalling in beating cardiomyocytes.
Isidori AM; Cornacchione M; Barbagallo F; Di Grazia A; Barrios F; Fassina L; Monaco L; Giannetta E; Gianfrilli D; Garofalo S; Zhang X; Chen X; Xiang YK; Lenzi A; Pellegrini M; Naro F
Cardiovasc Res; 2015 Jun; 106(3):408-20. PubMed ID: 25852085
[TBL] [Abstract][Full Text] [Related]
3. Chronic inhibition of cGMP-specific phosphodiesterase 5 suppresses endoplasmic reticulum stress in heart failure.
Gong W; Duan Q; Cai Z; Chen C; Ni L; Yan M; Wang X; Cianflone K; Wang DW
Br J Pharmacol; 2013 Dec; 170(7):1396-409. PubMed ID: 24032459
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting Insulin-Mediated β2-Adrenergic Receptor Activation Prevents Diabetes-Associated Cardiac Dysfunction.
Wang Q; Liu Y; Fu Q; Xu B; Zhang Y; Kim S; Tan R; Barbagallo F; West T; Anderson E; Wei W; Abel ED; Xiang YK
Circulation; 2017 Jan; 135(1):73-88. PubMed ID: 27815373
[TBL] [Abstract][Full Text] [Related]
5. Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes.
Xiao RP; Avdonin P; Zhou YY; Cheng H; Akhter SA; Eschenhagen T; Lefkowitz RJ; Koch WJ; Lakatta EG
Circ Res; 1999 Jan 8-22; 84(1):43-52. PubMed ID: 9915773
[TBL] [Abstract][Full Text] [Related]
6. PDE5 Inhibition Ameliorates Visceral Adiposity Targeting the miR-22/SIRT1 Pathway: Evidence From the CECSID Trial.
Fiore D; Gianfrilli D; Giannetta E; Galea N; Panio G; di Dato C; Pofi R; Pozza C; Sbardella E; Carbone I; Naro F; Lenzi A; Venneri MA; Isidori AM
J Clin Endocrinol Metab; 2016 Apr; 101(4):1525-34. PubMed ID: 26964730
[TBL] [Abstract][Full Text] [Related]
7. Heterologous desensitization of cardiac β-adrenergic signal via hormone-induced βAR/arrestin/PDE4 complexes.
Shi Q; Li M; Mika D; Fu Q; Kim S; Phan J; Shen A; Vandecasteele G; Xiang YK
Cardiovasc Res; 2017 May; 113(6):656-670. PubMed ID: 28339772
[TBL] [Abstract][Full Text] [Related]
8. High-fat diet induces protein kinase A and G-protein receptor kinase phosphorylation of β
Fu Q; Hu Y; Wang Q; Liu Y; Li N; Xu B; Kim S; Chiamvimonvat N; Xiang YK
J Physiol; 2017 Mar; 595(6):1973-1986. PubMed ID: 27983752
[TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice.
Wang L; Chopp M; Szalad A; Liu Z; Bolz M; Alvarez FM; Lu M; Zhang L; Cui Y; Zhang RL; Zhang ZG
Neuroscience; 2011 Oct; 193():399-410. PubMed ID: 21820491
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic Cardiomyopathy.
Di Luigi L; Corinaldesi C; Colletti M; Scolletta S; Antinozzi C; Vannelli GB; Giannetta E; Gianfrilli D; Isidori AM; Migliaccio S; Poerio N; Fraziano M; Lenzi A; Crescioli C
Inflammation; 2016 Jun; 39(3):1238-52. PubMed ID: 27165639
[TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase 5 inhibition ameliorates angiotensin II-dependent hypertension and renal vascular dysfunction.
Thieme M; Sivritas SH; Mergia E; Potthoff SA; Yang G; Hering L; Grave K; Hoch H; Rump LC; Stegbauer J
Am J Physiol Renal Physiol; 2017 Mar; 312(3):F474-F481. PubMed ID: 28052870
[TBL] [Abstract][Full Text] [Related]
12. PDE5 inhibitor efficacy is estrogen dependent in female heart disease.
Sasaki H; Nagayama T; Blanton RM; Seo K; Zhang M; Zhu G; Lee DI; Bedja D; Hsu S; Tsukamoto O; Takashima S; Kitakaze M; Mendelsohn ME; Karas RH; Kass DA; Takimoto E
J Clin Invest; 2014 Jun; 124(6):2464-71. PubMed ID: 24837433
[TBL] [Abstract][Full Text] [Related]
13. Muscle Damage in Systemic Sclerosis and CXCL10: The Potential Therapeutic Role of PDE5 Inhibition.
Corinaldesi C; Ross RL; Abignano G; Antinozzi C; Marampon F; di Luigi L; Buch MH; Riccieri V; Lenzi A; Crescioli C; Del Galdo F
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809279
[TBL] [Abstract][Full Text] [Related]
14. GRK2 blockade with βARKct is essential for cardiac β2-adrenergic receptor signaling towards increased contractility.
Salazar NC; Vallejos X; Siryk A; Rengo G; Cannavo A; Liccardo D; De Lucia C; Gao E; Leosco D; Koch WJ; Lymperopoulos A
Cell Commun Signal; 2013 Aug; 11():64. PubMed ID: 23984976
[TBL] [Abstract][Full Text] [Related]
15. Exploring the Multifaceted Potential of Sildenafil in Medicine.
Pușcașu C; Zanfirescu A; Negreș S; Șeremet OC
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138293
[TBL] [Abstract][Full Text] [Related]
16. Prevention of PKG-1α Oxidation Suppresses Antihypertrophic/Antifibrotic Effects From PDE5 Inhibition but not sGC Stimulation.
Nakamura T; Zhu G; Ranek MJ; Kokkonen-Simon K; Zhang M; Kim GE; Tsujita K; Kass DA
Circ Heart Fail; 2018 Mar; 11(3):e004740. PubMed ID: 29545395
[TBL] [Abstract][Full Text] [Related]
17. Gender-specific immunological effects of the phosphodiesterase 5 inhibitor sildenafil in healthy mice.
Karakhanova S; Yang Y; Link J; Soltek S; von Ahn K; Umansky V; Werner J; Bazhin AV
Mol Immunol; 2013 Dec; 56(4):649-59. PubMed ID: 23911424
[TBL] [Abstract][Full Text] [Related]
18. Chronic Inhibition of cGMP phosphodiesterase 5A improves diabetic cardiomyopathy: a randomized, controlled clinical trial using magnetic resonance imaging with myocardial tagging.
Giannetta E; Isidori AM; Galea N; Carbone I; Mandosi E; Vizza CD; Naro F; Morano S; Fedele F; Lenzi A
Circulation; 2012 May; 125(19):2323-33. PubMed ID: 22496161
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress regulates left ventricular PDE5 expression in the failing heart.
Lu Z; Xu X; Hu X; Lee S; Traverse JH; Zhu G; Fassett J; Tao Y; Zhang P; dos Remedios C; Pritzker M; Hall JL; Garry DJ; Chen Y
Circulation; 2010 Apr; 121(13):1474-83. PubMed ID: 20308615
[TBL] [Abstract][Full Text] [Related]
20. Sustained soluble guanylate cyclase stimulation offsets nitric-oxide synthase inhibition to restore acute cardiac modulation by sildenafil.
Nagayama T; Zhang M; Hsu S; Takimoto E; Kass DA
J Pharmacol Exp Ther; 2008 Aug; 326(2):380-7. PubMed ID: 18456872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
